Features Archives - Page 2 of 15

Sifted top healthtech accelerator in Europe

Features

BaseLaunch is top European accelerator

Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization BaselArea.swiss, is among the leading accelerators of its kind in Europe, according to a…

clement22.05.2019

Features

Our fully equipped lab space significantly reduces the cost to start a biotech

Launching a biotech is a daunting endeavor. Resources – both human and capital - are scarce and have to be fully dedicated to advancing science…

clement29.04.2019

Features

Roche takes Switzerland to number one for patents

In 2018, no other country in Europe saw more patents filed relative to population size than Switzerland. This has been found by a new report…

clement12.03.2019

Features

KPMG’s R&D 2030 report is out now

Our partner KPMG’s latest report on R&D 2030 sheds light on the expected evolution in the R&D ecosystem. It highlights how the ecosystem is due…

clement15.02.2019

Features

BaseLaunch funds four healthcare ventures

BaseLaunch supports carefully selected ventures in two phases. After a very intense pressure test period, four projects were selected for Phase II of our second…

clement22.01.2019

Features

Applications for 2019 are now open

We are excited to be open for new applications. We are looking for people and projects with breakthrough healthcare innovations mainly in the field of…

clement22.01.2019

Features

Looking for an experienced drug developer to join an emerging biotech

A company we are supporting is currently finalizing a substantial Series A round with leading European investors. To complement the team, they are currently looking…

clement22.01.2019

Features

Features

BaseLaunch is top European accelerator

Our fully equipped lab space significantly reduces the cost to start a biotech

Roche takes Switzerland to number one for patents

KPMG’s R&D 2030 report is out now

BaseLaunch funds four healthcare ventures

Applications for 2019 are now open

Looking for an experienced drug developer to join an emerging biotech

Versant partners gear up for a $700M bonanza of biotech bets, with a special focus all their own

A Harvard Professor Made $400 Million in Moderna’s Biotech IPO

Black Diamond turns down an open stretch of R&D highway, headed to a showdown with oncogenes

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us